WIF1 and familial pancreatic carcinoma: However, ALKBH5 overexpression sensitized pancreatic cancer cells to gemcitabine therapy and inhibited pancreatic cancer tumorigenesis by reducing the levels of m6A-dependent WNT inhibitory factor 1 (WIF-1) and hindering WNT signaling activation [89].